Phase II, two-stage study of avelumab in patients with microsatellite stable (MSS), microsatellite instable (MSI) and polymerase epsilon (POLE) mutated recurrent or persistent endometrial cancer
暂无分享,去创建一个
M. Birrer | S. Cannistra | William H. Barry | U. Matulonis | G. Fleming | D. Dizon | P. Konstantinopoulos | Joyce F. Liu | R. Penson | M. Buss | E. Stover | C. Krasner | S. Campos | S. Farooq | W. Luo | S. Schumer | A. Wright